Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.

MLA

Beccafico, Sara, et al. “Artesunate Induces ROS- and P38 MAPK-Mediated Apoptosis and Counteracts Tumor Growth in Vivo in Embryonal Rhabdomyosarcoma Cells.” Carcinogenesis, vol. 36, no. 9, Sept. 2015, pp. 1071–83. EBSCOhost, https://doi.org/10.1093/carcin/bgv098.

APA

Beccafico, S., Morozzi, G., Marchetti, M. C., Riccardi, C., Sidoni, A., Donato, R., & Sorci, G. (2015). Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells. Carcinogenesis, 36(9), 1071–1083. https://doi.org/10.1093/carcin/bgv098

Chicago

Beccafico, Sara, Giulio Morozzi, Maria Cristina Marchetti, Carlo Riccardi, Angelo Sidoni, Rosario Donato, and Guglielmo Sorci. 2015. “Artesunate Induces ROS- and P38 MAPK-Mediated Apoptosis and Counteracts Tumor Growth in Vivo in Embryonal Rhabdomyosarcoma Cells.” Carcinogenesis 36 (9): 1071–83. doi:10.1093/carcin/bgv098.